Explore. Learn. Grow.

Meet Dr. Scott Joyner: The Physician Behind Eleva MD's Bio-Individualized Approach to Women's Wellness 31 years of clinical experience. Thousands of women were treated.

You've heard about GLP-1 medications like Ozempic and Wegovy. You've seen the headlines about weight loss. But there's a story beyond the buzz—one that matters if you're dealing with metabolic health issues, PCOS, menopause symptoms, thyroid dysfunction, or chronic inflammation your previous doctors dismissed as "just stress."

For years, women have been told their weight, energy, and mood issues were a matter of discipline. Eat cleaner. Sleep more. Try harder. But when women in their 30s, 40s, and 50s suddenly start gaining weight, waking up at 3 a.m., losing their libido, or feeling “not like themselves,” this isn’t a motivation problem. It’s hormonal.

Women often describe midlife as feeling like they’re running on half-charged batteries—fatigue that sleep can’t fix, brain fog that appears out of nowhere, slower recovery, mood imbalances, and a resilience that feels “lower than it used to.” These aren’t character flaws. They’re cellular issues.

GLP-1 medications—Semaglutide, Tirzepatide, and their compounded microdose forms—are peptides. And peptides are fragile. Heat, freezing, or improper storage can damage their structure long before you ever inject or use them. When that happens, patients blame themselves for “not losing weight” or experiencing “unexpected nausea,” when the truth is simpler: The medication wasn’t potent.